MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova1, Fan Xia, Joseph Avruch
1Diabetes Unit and Medical Services and Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Background:
MST1 and MST2 are the mammalian Ste20-related protein kinases most closely related to Drosophila Hippo, a major regulator of cell proliferation and survival during development. Overexpression of MST1 or MST2 in mammalian cells is proapototic; however, little is known concerning the physiologic regulation of the endogenous MST1/MST2 kinases, their role in mammalian cell proliferation, or the identity of the MST1/MST2 substrates critical to proliferative regulation.
Results:
We show that MST1 and MST2 activity increases during mitosis, especially in nocodazole-arrested mitotic cells, where these kinases exhibit both an increase in both abundance and activation. MST1 and MST2 also can be activated nonphysiologically by okadaic acid or H2O2. The MOBKL1A and MOBKL1B polypeptides, homologs of the Drosophila MATS polypeptide, are identified as preferred MST1/MST2 substrates in vitro and are phosphorylated in cells in an MST1/MST2-dependent manner in mitosis and in response to okadaic acid or H2O2. MST1/MST2-catalyzed MOBKL1A/MOBKL1B phosphorylation alters the ability of MOBKL1A/MOBKL1B to bind and regulate downstream targets such as the NDR-family protein kinases. Thus, MOBKL1A/MOBKL1B phosphorylation in cells promotes MOBKL1A/MOBKL1B binding to the LATS1 kinase and enables H2O2-stimulated LATS1 activation loop phosphorylation. Most importantly, replacement of endogenous MOBKL1A/MOBKL1B by a nonphosphorylatable mutant is sufficient to accelerate cell proliferation substantially by speeding progression through G1/S as well as mitotic exit.
Conclusions:
These results establish that MST1 and MST2 are activated in mitosis and catalyze the mitotic phosphorylation of MOBKL1A/MOBKL1B. MOBKL1A/MOBKL1B phosphorylation, in turn, is sufficient to inhibit proliferation through actions at several points in the cell cycle.
Insights
Mammalian Ste20-related kinases MST1 and MST2 are activated during mitosis, phosphorylating MOBKL1A/MOBKL1B. This phosphorylation inhibits cell proliferation by regulating cell cycle progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- MST1 and MST2 are mammalian Ste20-related protein kinases homologous to Drosophila Hippo.
- Their role in mammalian cell proliferation and regulation is not well understood.
- Overexpression of MST1/MST2 is pro-apoptotic, but physiological regulation remains unclear.
Purpose of the Study:
- To investigate the physiological regulation of MST1 and MST2 kinases.
- To identify MST1/MST2 substrates involved in cell proliferation control.
- To elucidate the role of MST1/MST2 in mammalian cell cycle regulation.
Main Methods:
- Assessing MST1/MST2 kinase activity during mitosis and in response to stimuli (nocodazole, okadaic acid, H2O2).
- Identifying and characterizing MST1/MST2 substrates using in vitro and in cell assays.
- Utilizing non-phosphorylatable mutants to assess the functional impact of MOBKL1A/MOBKL1B phosphorylation.
Main Results:
- MST1 and MST2 activity and abundance increase during mitosis.
- MOBKL1A and MOBKL1B are identified as direct MST1/MST2 substrates, phosphorylated in mitosis and upon stimulation.
- Phosphorylation of MOBKL1A/MOBKL1B by MST1/MST2 promotes binding to LATS1 and enables LATS1 activation.
- Cells expressing non-phosphorylatable MOBKL1A/MOBKL1B exhibit accelerated proliferation.
Conclusions:
- MST1 and MST2 are activated during mitosis and phosphorylate MOBKL1A/MOBKL1B.
- Mitotic phosphorylation of MOBKL1A/MOBKL1B by MST1/MST2 is a key regulator of cell proliferation.
- This regulatory mechanism impacts cell cycle progression at multiple points.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Inhibition of Cdk Activity


